PYRGF
PyroGenesis Canada Inc.·Industrials
0.21
2.804%(−0.01)
Close PriceLast Updated: — ET
52W L: $0.1252W H: $0.53
PYRGF NEWS
globenewswire.com
May 20
PyroGenesis Announces Upsize of Bought Deal LIFE Offering to $3.7 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 20, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. ("PyroGenesis" or the "Company") (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry and defense, announces today that due to strong investor demand, it has entered into an amendment agreement with Research Capital Corporation ("RCC"), as the sole underwriter and sole bookrunner (the "Underwriter"), to increase the size of its previously announced "bought deal" offering, pursuant to which the Underwriter has agreed to purchase, on a "bought deal" basis pursuant to the Listed Issuer Financing Exemption ("LIFE"), 10,882,500 units of the Company (the "Units") for aggregate gross proceeds to the Company of $3,700,050 (the "Offering") at a price per Unit of $0.
globenewswire.com
May 20
PyroGenèse annonce l’augmentation du montant de son placement par prise ferme sous la dispense de l’émetteur coté pour le porter à 3,7 millions de dollars
Ne pas distribuer aux services de transmission des États-Unis ni diffuser aux États-Unis MONTRÉAL, 20 mai 2026 (GLOBE NEWSWIRE) -- PyroGenèse Inc. (« PyroGenèse » ou la « Société ») (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), chef de file des procédés à ultra-haute température et de l'innovation en ingénierie, ainsi que fournisseur de technologies plasma pour les industries lourdes et la défense, annonce aujourd'hui qu'en raison de la forte demande des investisseurs, elle a conclu un accord modificateur avec Research Capital Corporation (« RCC »), agissant à titre de seul preneur ferme et seul teneur de livres (le « preneur ferme »), en vue d'augmenter le montant de son placement par prise ferme précédemment annoncée, aux termes duquel le preneur ferme a convenu d'acheter, dans le cadre d'un placement privé par prise ferme réalisé conformément à la dispense pour financement de l'émetteur coté, 10 882 500 unités de la Société (les « unités ») pour un produit brut global de 3 700 050 $ pour la Société (le « placement »), au prix de 0,34 $ par unité (le « prix du placement »).
globenewswire.com
May 20
PyroGenesis Announces Upsize of Bought Deal LIFE Offering to $3.7 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 20, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis” or the “Company”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that due to strong investor demand, it has entered into an amendment agreement with Research Capital Corporation (“RCC”), as the sole underwriter and sole bookrunner (the “Underwriter”), to increase the size of its previously announced “bought deal” offering, pursuant to which the Underwriter has agreed to purchase, on a “bought deal” basis pursuant to the Listed Issuer Financing Exemption (“LIFE”), 10,882,500 units of the Company (the “Units”) for aggregate gross proceeds to the Company of $3,700,050 (the “Offering”) at a price per Unit of $0.34 (the “Offering Price”). Each Unit will consist of one common share of the Company (a “Common Share”) and one Common Share purchase warrant of the Company (a “Warrant”).
globenewswire.com
May 19
PyroGenesis Announces $3.0 Million Bought Deal LIFE Offering and Concurrent CEO Private Placement of up to $2.0 Million
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 19, 2026 (GLOBE NEWSWIRE) -- PyroGenesis Inc. ("PyroGenesis" or the "Company") (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry and defense, announces today that it has entered into an agreement with Research Capital Corporation ("RCC") to act as the sole underwriter and sole bookrunner (the "Underwriter"), pursuant to which the Underwriter has agreed to purchase, on a "bought deal" basis pursuant to the Listed Issuer Financing Exemption ("LIFE"), 8,825,000 units of the Company (the "Units") for aggregate gross proceeds to the Company of $3,000,500 (the "Offering") at a price per Unit of $0.
globenewswire.com
May 19
PyroGenesis annonce un placement par prise ferme de 3,0 millions de dollars sous la dispense de l’émetteur côté et un placement privé concomitant par le chef de la direction pouvant atteindre 2,0 millions de dollars
Ne pas distribuer aux services de transmission des États-Unis ni diffuser aux États-Unis MONTRÉAL, 19 mai 2026 (GLOBE NEWSWIRE) -- PyroGenèse Inc. (« PyroGenèse » ou la « Société ») (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), chef de file des procédés à ultra-haute température et de l'innovation en ingénierie, ainsi que fournisseur de technologies plasma pour les industries lourdes et la défense, annonce aujourd'hui qu'elle a conclu une convention avec Research Capital Corporation (« RCC ») agissant à titre de seul preneur ferme et seul teneur de livres (le « preneur ferme »), aux termes de laquelle le preneur ferme a convenu d'acheter, dans le cadre d'un placement privé par prise ferme réalisé conformément à la dispense pour financement de l'émetteur coté, 8 825 000 unités de la Société (les « unités ») pour un produit brut global de 3 000 500 $ pour la Société (le « placement »), au prix de 0,34 $ par unité (le « prix du placement »).
newsfilecorp.com
May 19
PyroGenesis Announces $3.0 Million Bought Deal LIFE Offering and Concurrent CEO Private Placement of up to $2.0 Million
Montreal, Quebec--(Newsfile Corp. - May 19, 2026) - PyroGenesis Inc. (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1) ("PyroGenesis" or the "Company"), a leader in ultra-high temperature processes and engineering innovation, and a plasma-based technology provider to heavy industry & defense, announces today that it has entered into an agreement with Research Capital Corporation ("RCC") to act as the sole underwriter and sole bookrunner (the "Underwriter"), pursuant to which the Underwriter has agreed to purchase, on a "bought deal" basis pursuant to the Listed Issuer Financing Exemption ("LIFE"), 8,825,000 units of the Company (the "Units") for aggregate gross proceeds to the Company of $3,000,500 (the "Offering") at a price per Unit of $0.34 (the "Offering Price"). Each Unit will consist of one common share of the Company (a "Common Share") and one Common Share purchase warrant of the Company (a "Warrant").
